Gilead Built HIV Drug Empire On 'No Generic' Deals, Suit Says

By Jeff Overley · May 14, 2019, 9:50 PM EDT

Despite abysmal scientific innovation, Gilead Sciences Inc. constructed an HIV drug empire worth tens of billions of dollars by devising shadowy deals to block the use of lower-cost generics in combo...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In re HIV Antitrust Litigation

Case Number

3:19-cv-02573

Court

California Northern

Nature of Suit

Anti-Trust

Date Filed

May 14, 2019